Annual report pursuant to Section 13 and 15(d)

Geographic information

v3.20.4
Geographic information
12 Months Ended
Dec. 31, 2020
Geographic information  
Geographic information

Note 14 — Geographic information

Operations by geographic area

Revenue represents recognized income from Astellas Collaboration Agreement and the GSK Collaboration and License Agreement. All revenue was derived in the United Kingdom.

Long-lived assets (excluding intangibles and financial instruments) were located as follows (in thousands):

December 31, 

December 31, 

    

2020

    

2019

U.K.

$

24,329

$

27,367

U.S.

 

22,329

 

24,490

Total long-lived assets(1)

$

46,658

$

51,857

(1) Clinical materials of $nil and $2,503,000, included within non-current assets as of December 31, 2020 and 2019, respectively, are not included within the table above because they can easily be transferred between geographic locations.

Major customers:

During the year ended December 31, 2020, 52% and 48% of the Company’s revenues were generated from Astellas and GSK, respectively. During the year ended December 31, 2019, 100% of revenues were generated from GSK.